跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
SUPIROCIN mupirocin (as calcium) 2% w/w cream tube
Approved
STANDARD
SUPIROCIN mupirocin (as calcium) 2% w/w cream tube
Glenmark Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
6ef349ed334d8da6
Company
Glenmark Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
6ef349ed334d8da6
Product Name
SUPIROCIN mupirocin (as calcium) 2% w/w cream tube
Artg Id
385530
Artg Name
SUPIROCIN mupirocin (as calcium) 2% w/w cream tube
Sponsor
Glenmark Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/glenmark-pharmaceuticals-australia-pty-limited
Artg Date
2023-05-24
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-CMI-01830-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-PI-01831-1
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
6ef349ed334d8da6
Type
Standard
Back to TGA Approvals
SUPIROCIN mupirocin (as calcium) 2% w/w cream tube - TGA Drug Approval Details
